Catalyst Wire Dossier Catalyst Wire Dossier

BioNTech COVID-19 RNA Vaccine Candidate (Variant-Adapted)

· BioNTech SE
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BioNTech COVID-19 RNA Vaccine Candidate (Variant-Adapted), covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children [Phase 3]

See pricing